Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Solosec® (secnidazole) – New indication
July 1, 2021 - Lupin Pharmaceuticals announced the FDA approval of Solosec (secnidazole), for the treatment of trichomoniasis caused by Trichomonas vaginalis (T. vaginalis) in adults.
